Verified Nov 2026
Other
·
Chaska, Minnesota
·
Since 1965
Lifecore Biomedical is a contract development and manufacturing organization headquartered in Chaska, Minnesota, and founded in 1965. It produces pharmaceutical-grade, non-animal-sourced hyaluronic acid and provides formulation development, cGMP manufacturing, and aseptic fill/finish for sterile injectable products. The company has 200-500 employees, is publicly traded under the ticker LFCR, and serves the medical, automotive, electric-vehicle, and industrial-equipment sectors. In 2026 it announced it would be acquired by Webster Equity Partners.
Lifecore Biomedical at a glance
Revenue
129.5M
Employees
200-500
Founded
1965
Headquarters
Chaska, Minnesota
Ownership
Publicly traded (NASDAQ: LFCR)
Certifications
ISO 13485
Import activity
90
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
90
Named foreign suppliers
10
Top origins
Belgium · Italy · Germany · Spain
Shared foreign counterparties do not establish that these companies buy from Lifecore Biomedical.
What this tells a buyer
Lifecore reported a series of new agreements in 2026, including a June contract with a new biopharmaceutical customer, a June agreement with a global pharmaceutical company, and a September commercial site transfer agreement, with its third-quarter 2026 results released in November 2026.
The company holds ISO 13485 certification and offers aseptic fill/finish of viscous products, sterile injectable manufacturing, and hydrogel-based specialty formulations.
Lifecore reports revenue of approximately $129.5 million and is publicly listed under the ticker LFCR, with its ownership expected to change following the announced acquisition by Webster Equity Partners.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & strong
61 years in operation (founded 1965).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
Lifecore Biomedical is a contract development and manufacturing organization headquartered in Chaska, Minnesota, and founded in 1965. It produces pharmaceutical-grade, non-animal-sourced hyaluronic acid and provides formulation development, cGMP manufacturing, and aseptic fill/finish for sterile injectable products. The company has 200-500 employees, is publicly traded under the ticker LFCR, and serves the medical, automotive, electric-vehicle, and industrial-equipment sectors. In 2026 it announced it would be acquired by Webster Equity Partners.
At a glance
Attribute | Detail |
|---|---|
Founded | 1965 |
Headquarters | Chaska, Minnesota |
Employees | 200-500 |
Revenue | 129.5M |
Ownership | Publicly traded (NASDAQ: LFCR) |
Certifications | ISO 13485 |
What Lifecore Biomedical makes
The company holds ISO 13485 certification and offers aseptic fill/finish of viscous products, sterile injectable manufacturing, and hydrogel-based specialty formulations.
Products and capabilities described on the company's own site include Suspension, Pump, Assembly (source: lifecore.com).
Certifications
Lifecore Biomedical is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — lifecore.com
Trade and customs footprint
Lifecore reported a series of new agreements in 2026, including a June contract with a new biopharmaceutical customer, a June agreement with a global pharmaceutical company, and a September commercial site transfer agreement, with its third-quarter 2026 results released in November 2026. US customs bill-of-lading records list 90 inbound shipments across 10 foreign suppliers, with top origins including Belgium · Italy · Germany · Spain.
Latest developments
2026-11-04 — Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update | Lifecore Biomedical (lifecore.com)
2026-09-28 — Lifecore Biomedical to be Acquired by Webster Equity Partners | Lifecore Biomedical (lifecore.com)
2026-09-02 — Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company | Lifecore Biomedical (lifecore.com)
2026-06-15 — Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company | Lifecore Biomedical (lifecore.com)
2026-06-02 — Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer | Lifecore Biomedical (lifecore.com)
2026-03-26 — Lifecore Biomedical Signs Two New Agreements with Existing (globenewswire.com)
Facilities
Lifecore Biomedical is headquartered in Chaska, Minnesota. Public sources also reference these locations:
Chaska, MN — contractpharma.com
Company details
Lifecore reports revenue of approximately $129.5 million and is publicly listed under the ticker LFCR, with its ownership expected to change following the announced acquisition by Webster Equity Partners. Lifecore Biomedical was founded in 1965, has an estimated 200-500 employees, and is headquartered in Chaska, Minnesota. On the LightSource stability read it is rated "Established & strong": 61 years in operation (founded 1965). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Lifecore Biomedical do?
Lifecore Biomedical is a contract development and manufacturing organization headquartered in Chaska, Minnesota, and founded in 1965. It produces pharmaceutical-grade, non-animal-sourced hyaluronic acid and provides formulation development, cGMP manufacturing, and aseptic fill/finish for sterile injectable products. The company has 200-500 employees, is publicly traded under the ticker LFCR, and serves the medical, automotive, electric-vehicle, and industrial-equipment sectors. In 2026 it announced it would be acquired by Webster Equity Partners.
Where is Lifecore Biomedical headquartered?
Lifecore Biomedical is headquartered in Chaska, Minnesota (3515 Lyman Boulevard, Chaska, Minnesota, 55318).
When was Lifecore Biomedical founded?
Lifecore Biomedical was founded in 1965.
How big is Lifecore Biomedical?
Lifecore Biomedical has an estimated 200-500 employees, with revenue in the 129.5M range.
Is Lifecore Biomedical publicly traded?
Publicly traded (NASDAQ: LFCR). Public financial figures are drawn from its filings.
What certifications does Lifecore Biomedical hold?
Lifecore Biomedical lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.